NeoVirTech SAS, Centre Pierre Potier, Toulouse, France; IHAP, Université de Toulouse, INRAE, ENVT, Toulouse, France.
NeoVirTech SAS, Centre Pierre Potier, Toulouse, France.
J Virol Methods. 2021 Aug;294:114194. doi: 10.1016/j.jviromet.2021.114194. Epub 2021 May 19.
Equine herpesvirus 1 (EHV-1) is a causative agent of respiratory disorders, abortion and myeloencephalopathy in horses and has an important impact on equine health and economy. Several bacterial artificial chromosomes have already been developed and enabled identification and functional characterization of EHV-1 genes. Unfortunately, little is known about its replication. Here, the ANCHOR system was inserted by targeted homologous recombination into the equine herpesvirus genome. This insertion led to the conversion of EHV-1 DNA to auto-fluorescent spots easily detectable by fluorescence microscopy, and enabled production of an auto-fluorescent EHV-1 ANCHORGFP with tropism and replication kinetic like the parental strain. High resolution imaging allowed first visualization of EHV-1 replication from apparition of first viral genome to large replicative centers, in single cells or inside syncytia. Combined with high content microscopy, EHV-1 ANCHORGFP leads to identification of auranofin and azacytidine-5 as new potential antivirals to treat EHV-1 infection.
马疱疹病毒 1 型(EHV-1)是引起马呼吸道疾病、流产和脑脊髓炎的病原体,对马的健康和经济有重要影响。已经开发了几种细菌人工染色体,能够鉴定和功能表征 EHV-1 基因。不幸的是,人们对其复制知之甚少。在这里,通过靶向同源重组将 ANCHOR 系统插入马疱疹病毒基因组中。这种插入导致 EHV-1 DNA 转化为自动荧光斑点,通过荧光显微镜很容易检测到,并且能够产生具有与亲本株类似的嗜性和复制动力学的自动荧光 EHV-1 ANCHORGFP。高分辨率成像允许首次观察到 EHV-1 的复制,从第一个病毒基因组的出现到单个细胞或合胞体中的大复制中心。与高内涵显微镜结合使用,EHV-1 ANCHORGFP 鉴定出金诺芬和阿扎胞苷-5 是治疗 EHV-1 感染的新的潜在抗病毒药物。